These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11151751)

  • 1. Diffusion of enoxacin and its oxo-metabolite into human epididymal tissue.
    Hamel B; Mottet N; Audran M; Costa P; Bressolle F
    Eur J Clin Pharmacol; 2000 Nov; 56(8):597-8. PubMed ID: 11151751
    [No Abstract]   [Full Text] [Related]  

  • 2. [Enoxacin concentration in human prostatic tissue after 3-day administration].
    Morita M; Kato M; Kuji S; Hasuda A
    Hinyokika Kiyo; 1988 Jul; 34(7):1293-6. PubMed ID: 2459943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversed-phase high-performance liquid chromatographic determination of enoxacin and 4-oxo-enoxacin in human plasma and prostatic tissue. Application to a pharmacokinetic study.
    Hamel B; Audran M; Costa P; Bressolle F
    J Chromatogr A; 1998 Jul; 812(1-2):369-79. PubMed ID: 9691332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of enoxacin and its oxometabolite after multiple oral dosing and penetration into prostatic tissue.
    Hamel B; Mottet N; Audran M; Costa P; Bressolle F
    J Antimicrob Chemother; 2000 Dec; 46(6):993-6. PubMed ID: 11102420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The diffusion of enoxacin into the prostatic fluid in the chronic prostatitis patient].
    Tanaka K; Nakano Y; Ono Y; Hirabayashi S; Yamada S
    Hinyokika Kiyo; 1988 Nov; 34(11):2067-9. PubMed ID: 3242374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The possible mechanism of interaction between xanthines and quinolone.
    Hasegawa T; Nadai M; Kuzuya T; Muraoka I; Apichartpichean R; Takagi K; Miyamoto K
    J Pharm Pharmacol; 1990 Nov; 42(11):767-72. PubMed ID: 1982300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Henwood JM; Monk JP
    Drugs; 1988 Jul; 36(1):32-66. PubMed ID: 3063494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enoxacin penetration into human prostatic tissue.
    Bergeron MG; Roy R; Lessard C; Foucault P
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1433-4. PubMed ID: 3196004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution kinetics of enoxacin and its metabolite oxoenoxacin in excretory fluids of healthy volunteers.
    Jaehde U; Sörgel F; Naber KG; Zürcher J; Schunack W
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2092-7. PubMed ID: 8540722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparative trial of short-term orally administered enoxacin in the prevention of urinary infection after elective transurethral prostatectomy: a clinical and pharmacokinetic study.
    Desai KM; Abrams PH; White LO
    J Urol; 1988 Jun; 139(6):1232-4. PubMed ID: 2453683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of enoxacin in elderly patients.
    Wise R; Baker SL; Misra M; Griggs D
    J Antimicrob Chemother; 1987 Mar; 19(3):343-50. PubMed ID: 3471751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo diffusion of enoxacin in healthy renal and adenomatous prostate tissue in man.
    Charton M; Timbal Y
    Eur Urol; 1990; 17(3):252-6. PubMed ID: 1693576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study on enoxacin concentration in human prostatic tissue].
    Kitamura Y; Kataumi Z; Nakamura T; Takeda H
    Hinyokika Kiyo; 1990 Jan; 36(1):101-2. PubMed ID: 1689927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of enoxacin, ofloxacin, and norfloxacin concentration in human benign prostatic tissue].
    Yasumoto R; Asakawa M
    Hinyokika Kiyo; 1988 Aug; 34(8):1519-21. PubMed ID: 3195414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of enoxacin in subjects with renal or hepatic impairment.
    Novelli A; Reali EF; Amato M; Dami A; Fallani S; Periti P
    J Chemother; 1989 Jul; 1(4 Suppl):546-8. PubMed ID: 16312526
    [No Abstract]   [Full Text] [Related]  

  • 16. Circadian variation in enoxacin-induced convulsions in mice coadministered with fenbufen.
    Masukawa T; Nakanishi K
    Jpn J Pharmacol; 1997 Feb; 73(2):175-7. PubMed ID: 9074952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of enoxacin and 4-oxo-enoxacin on antipyrine disposition in the rat.
    Edwards DJ; Waite NM; Svensson CK
    Drug Metab Dispos; 1988; 16(4):653-5. PubMed ID: 2903039
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of enoxacin and norfloxacin in patients with cystitis.
    Yamamoto M; Nagai T; Takaba H; Hashimoto J; Miyake K
    Hinyokika Kiyo; 1987 Dec; 33(12):2141-4. PubMed ID: 3482344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinolone penetration into canine vaginal and urethral secretions.
    Gasser TC; Graversen PH; Larsen EH; Dørflinger T
    Scand J Urol Nephrol Suppl; 1987; 104():101-5. PubMed ID: 3481457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration of enoxacin into lung tissue.
    Newsom SW; Eden CG; Wells FC; Meredith P
    J Antimicrob Chemother; 1989 Jan; 23(1):113-5. PubMed ID: 2745246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.